TECHNICAL BULLETIN Neutrogena Dermatologics
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11 -
Safety of Oxybenzone: Putting Numbers Table
Safety of Oxybenzone: Putting Numbers Table. Years of Daily Sunscreen Application Required by an Average US Woman to Reach Systemic Levels Into Perspective of Oxybenzone per Unit of Body Mass Equivalent to Those Given to Immature Rats10 xybenzone, an organic UV-B and short-wave UV-A filter, has been available for over 40 years1; Scenario Scenario Scenario it is widely used in sunscreens and other con- Characteristic 1 2 3 O 2 sumer products in the United States. The Centers for Dis- Body surface area covered, % 100 100 25 ease Control and Prevention has estimated the preva- Application dose, mg/cm2/d211 lence of oxybenzone exposure in the general US Application amount required, 30.00 15.00 3.75 population to be 96.8%.3 In the past few years, oxyben- mL/d Time required, y 34.6 69.3 277.0 zone has received increasing attention as a potentially harmful compound. Initial concerns arose when a re- port demonstrated systemic absorption of oxybenzone in humans at a rate of 1% to 2% after topical applica- For the purposes of this estimation, a generous in-use dose of 1 mg/cm2 was used,13-16 and it was assumed that cov- tion.4 Similar or higher rates of cutaneous absorption in 5-9 erage of 25% of the human BSA was limited to the face, human subjects have been observed. The potential for neck, hands, and arms.17 biological effects, however, were first published in a study 10 by Schlumpf et al demonstrating uterotropic effects in Results. The numbers of years of daily application re- immature rats after oral administration of oxybenzone; quired to obtain the equivalent amount of sunscreen un- it should be noted that the estrogenic effect detected was der the 3 scenarios are listed in the Table. -
May 23, 2007 Office of Pesticide Programs
May 23, 2007 Office of Pesticide Programs (OPP) Regulatory Public Docket (7502P) Environmental Protection Agency 1200 Pennsylvania Ave., NW Washington, DC 20460-0001 RE: Insect Repellent-Sunscreen Combination Products [EPA-HQ-OPP-2007-0087] Beyond Pesticides appreciates the prudent contemplation of insect repellent-sunscreen combination products EPA proposed in the reregistration eligibility decision (RED) for N,N-diethyl-meta-toluamide (DEET). We also appreciate this opportunity to share our concerns over these products. Beyond Pesticides interest in this issue lies in our effort to restrict pesticide use in a manner that protects public health and the environment, and to advance alternatives that eliminate dependency on toxic chemicals. We oppose the reregistration of all DEET-sunscreen combination products for the following reasons: 1. DEET exposure can result in negative health effects. As the agency notes, the registration of DEET is unusual in that it is one of few residential-use pesticides that is applied directly to the skin. The result is that the public is being exposed to a pesticide that has the ability to cause in lab animals increased fetal loss, bone and skeleton abnormalities in the offspring of rabbits, birth defects in birds, reduction in size of the testes and degeneration, and has produced abnormal sperm with reduced motility. Additionally, the public is directly applying a chemical to their skin that is demonstrated to cross the placenta and move into fetal blood in humans, has the ability to cause mutagenicity and oxidative stress, can decrease sensory and motor skills, causes skin irritation and kills brain cells.1 2. Sunscreen exposure can result in negative health effects. -
GAO-18-61, SUNSCREEN: FDA Reviewed Applications For
United States Government Accountability Office Report to Congressional Committees November 2017 SUNSCREEN FDA Reviewed Applications for Additional Active Ingredients and Determined More Data Needed GAO-18-61 November 2017 SUNSCREEN FDA Reviewed Applications for Additional Active Ingredients and Determined More Data Needed Highlights of GAO-18-61, a report to congressional committees Why GAO Did This Study What GAO Found Using sunscreen as directed with other The Food and Drug Administration (FDA), within the Department of Health and sun protective measures may help Human Services, implemented requirements for reviewing applications for reduce the risk of skin cancer—the sunscreen active ingredients within time frames set by the Sunscreen Innovation most common form of cancer in the Act, which was enacted in November 2014. For example, the agency issued a United States. In the United States, guidance document on safety and effectiveness testing in November 2016. sunscreen is considered an over-the- counter drug, which is a drug available As of August 2017, all applications for sunscreen active ingredients remain to consumers without a prescription. pending after the agency determined more safety and effectiveness data are Some sunscreen active ingredients not needed. By February 2015, FDA completed its initial review of the safety and currently marketed in the United States effectiveness data for each of the eight pending applications, as required by the have been available in products in act. FDA concluded that additional data are needed to determine that the other countries for more than a ingredients are generally recognized as safe and effective (GRASE), which is decade. Companies that manufacture needed so that products using the ingredients can subsequently be marketed in some of these ingredients have sought the United States without FDA’s premarket approval. -
Toxic Effects
Chapter 8 Toxic effects Toxic and other adverse effects studies of tens or hundreds of patients spectrum to which the skin is exposed of sunscreens (Thune, 1984; English et al., 1987; (Gasparro et al., 1998). Since UVB is the In order for a sunscreen to have a toxic Lenique et al., 1992; Szczurko et al., primary stimulus for adaptation of the effect on living tissues, it must penetrate 1994; Trevisi et al., 1994; Gonçalo et al., skin to sunlight, less adaptation might be the skin. There is some evidence that 1995; Ang et al., 1998) and reviews expected to develop in individuals who this can occur (see p. 63 et seq.). (Dromgoole & Maibach, 1990; Gonzalez use sunscreens regularly. The adaptive & Gonzalez, 1996; Schauder & Ippen, responses include thickening of the epi- Human studies 1997). In the past, PABA and its esters dermis and transfer of melanin-contain- No published studies of toxic effects in were the most commonly reported ing granules to keratinocytes (tanning) humans were available to the Working contact and photoallergens in sun- (Fig. 44), which reduces the trans- Group. screens (Funk et ai., 1997), and this find- parency of the skin to UVA and UVB ing contributed to a reduction in their use (Fusaro et al., 1966; Olson et al., 1973). Contact sensitivity in sunscreens. The contact or photocon- Several reports showed that UVR- There are numerous reports of cases of tact allergen in sunscreens most induced injury, such as dermal connec- allergic reactions and photoreactivity to frequently cited today is benzophenone- tive tissue damage and sunburn cell for- sunscreens, but the prevalence of this 3, followed by dibenzoyl methanes. -
Two-Step Semi-Microscale Preparation of a Cinnamate Ester Sunscreen Analog W
In the Laboratory edited by The Microscale Laboratory R. David Crouch Dickinson College Carlisle, PA 17013-2896 Two-Step Semi-Microscale Preparation of a Cinnamate Ester Sunscreen Analog W Ryan G. Stabile and Andrew P. Dicks* Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario, Canada, M5S 3H6; *[email protected] Several laboratory experiments concerning the physical A two-step procedure using 4-methoxybenzaldehyde as properties of sunscreens have appeared in this Journal dur- the starting material (Scheme I) synthesizes ethyl trans-4- ing the last decade (1–5). These include quantification of methoxycinnamate 1. In the first laboratory session students commercial formulations by liquid chromatography (1) and are exposed to an important carbon–carbon bond forming ultraviolet (UV) spectrophotometry (2–4). The photochem- condensation reaction. The Verley–Doebner modification of istry of sunscreens has also been reviewed (6). Significantly, the Knoevenagel condensation (11) affords facile synthesis a student procedure focusing on multistep sunscreen synthesis of trans-4-methoxycinnamic acid, which is isolated and char- and spectroscopic analysis has not, to our knowledge, been acterized. During the second period, esterification is effected reported. Given the current high profile nature of skin can- by a cesium base mediated O-alkylation approach. This ex- cer (7) and media attention towards sunscreens, we designed emplifies the so-called “cesium effect” (12) and the useful- a two-step synthetic pathway towards an analog of a com- ness of cesium carboxylates as nucleophiles in SN2 reactions. mercially available UV light blocker. This methodology is in- In addition to stimulating class enthusiasm towards syn- corporated into a third-year undergraduate organic synthesis thetic chemistry, this experiment impresses many organic course at the University of Toronto. -
Ultraviolet Radiation, Aging and the Skin: Prevention of Damage by Topical Camp Manipulation
Molecules 2014, 19, 6202-6219; doi:10.3390/molecules19056202 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Ultraviolet Radiation, Aging and the Skin: Prevention of Damage by Topical cAMP Manipulation Alexandra Amaro-Ortiz 1, Betty Yan 1 and John A. D’Orazio 1,2,* 1 The Graduate Center for Toxicology, the Markey Cancer Center and the Department of Pediatrics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA 2 Markey Cancer Center, University of Kentucky College of Medicine, Combs Research Building 204, 800 Rose Street, Lexington, KY 40536-0096, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-859-323-6238; Fax: +1-859-257-8940. Received: 26 April 2014; in revised form: 8 May 2014 / Accepted: 13 May 2014 / Published: 15 May 2014 Abstract: Being the largest and most visible organ of the body and heavily influenced by environmental factors, skin is ideal to study the long-term effects of aging. Throughout our lifetime, we accumulate damage generated by UV radiation. UV causes inflammation, immune changes, physical changes, impaired wound healing and DNA damage that promotes cellular senescence and carcinogenesis. Melanoma is the deadliest form of skin cancer and among the malignancies of highest increasing incidence over the last several decades. Melanoma incidence is directly related to age, with highest rates in individuals over the age of 55 years, making it a clear age-related disease. In this review, we will focus on UV-induced carcinogenesis and photo aging along with natural protective mechanisms that reduce amount of “realized” solar radiation dose and UV-induced injury. -
Photophysics and Skin Penetration of Active Agents in a Commercial Sunscreen and Insect Repellent
PHOTOPHYSICS AND SKIN PENETRATION OF ACTIVE AGENTS IN A COMMERCIAL SUNSCREEN AND INSECT REPELLENT by DONALD PRETTYPAUL A Dissertation submitted to the Graduate School-Newark Rutgers, The State University of New Jersey In partial fulfillment of the requirements for the degree of Doctor of Philosophy Graduate Program in Chemistry written under the direction of Professor Richard Mendelsohn Professor Piotr Piotrowiak and approved by Newark, New Jersey October 2018 ©2018 Donald Prettypaul ALL RIGHTS RESERVED ABSTRACT OF DISSERTATION PHOTOPHYSICS AND SKIN PENETRATION OF ACTIVE AGENTS IN A COMMERCIAL SUNSCREEN AND INSECT REPELLENT By DONALD PRETTYPAUL Dissertation co-Directors: Professor Richard Mendelsohn Professor Piotr Piotrowiak This dissertation is focused on active agents in commercial sunscreen and insect repellent products. It consists of two parts, the first focusing on the photophysics of a sunscreen active agent and the second on the permeation and spatial distribution of the sunscreen active and an insect repellent active when these agents are applied to ex-vivo human skin. In the photochemistry study, ultrafast spectroscopy was used to study the excited state dynamics of the sunscreen molecule, Bemotrizinol. The work focused on the dissipation rates of the electronic excitation energy in different solvents. To complement the results from time-resolved femtosecond spectroscopy, Hartree- Fock UH/UHF 6-31G* calculations were used to characterize the ground and excited states potential energy surfaces. The results indicate that the excited state deactivation pathway follows a proton coupled electron transfer process which ii proceeds via a concerted mechanism. The dependencies on solvent polarity, viscosity, and H/D isotope effects, were investigated. Sunscreen products have been developed to protect skin from ultraviolet (UV) radiation; to achieve adequate protection, the sunscreen must be evenly applied and remain on the surface of the skin. -
New Technology Provides Cosmetically Elegant Photoprotection Zoe Diana Draelos, MD; Christian Oresajo; Margarita Yatskayer; Angelike Galdi; Isabelle Hansenne
COSMETIC CONSULTATION New Technology Provides Cosmetically Elegant Photoprotection Zoe Diana Draelos, MD; Christian Oresajo; Margarita Yatskayer; Angelike Galdi; Isabelle Hansenne he primary preventable cause of photoaging is United States, as there is no official rating system for exposure to UVA radiation. This wavelength UVA photoprotection yet. T emitted by the sun is present year round in all Ecamsule absorbs UVA radiation in the range of 320 to latitudes. Currently, the majority of sun-protective prod- 360 nm, but its peak absorbance occurs at 345 nm. It is ucts provide excellent UVB protection with minimal UVA typically combined with other organic sunscreen ingredi- protection. Although UVB protection is important in ents, such as avobenzone and octocrylene. Avobenzone, order to prevent sun damage to the skin from occurring, which is a photounstable photoprotectant, becomes UVA protection is equally important. New developments photostable when combined with octocrylene. These in raw material science have led to the manufacture of ingredients yield a photostable broad-spectrum sunscreen novel ingredients able to provide unprecedented photo- combination. However, the active sunscreen agents are protection COSin the UVA spectrum. DERMonly part of the formulation. Also important in sunscreen One of the most significant developments in cutaneous is the construction of the vehicle to deliver the photo- UVA protection was the discovery of ecamsule (Figure 1), protectants in an aesthetically pleasing manner, enticing also known as Mexoryl SX. Mexoryl SX, which has patients to wear the product. Sunscreens fail to be effec- the International Nomenclature of Cosmetic Ingredients tive if they remain in the bottle. name of terephthalylidene dicamphor sulfonic acid, is In order to evaluate the efficacy and tolerability of a water soluble. -
1. Background and Action Requested
June 27, 2019 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Comments Submitted to Docket No. 1978N-0018 (Formerly Docket No. FDA–1978–N– 0038) for “Sunscreen Drug Products for Over-the-Counter Human Use,” Regulatory Information No. 0910-AF43 DSM Nutritional Products LLC (“DSM”) is pleased to provide the following comments in response to the Food and Drug Administration’s (FDA’s) Tentative Final Monograph (“TFM”) for Sunscreen Drug Products Over-the-Counter (OTC) Human Use, published at 84 Fed. Reg. 6204 (February 26, 2019). As a global science-based company active in Nutrition, Health and Sustainable Living, DSM is a world leading supplier of vitamins, feed, food, pharmaceutical, cosmetic, personal care and aroma ingredients. In sunscreens, DSM is a leading world-wide provider of numerous UV filters, including Avobenzone. DSM takes human health and safety very seriously and believes that sunscreens are proven and effective interventions that help provide consumer protection against skin cancers and skin damage caused by the sun’s rays. DSM is committed to proactively supporting the safety and availability of existing and new sunscreen active ingredients that help protect public health. DSM requests that FDA modify its proposed rule taking into consideration the comments provided herein. 1. Background and Action Requested Skin cancer is a significant, and largely preventable, public health concern. Sunscreens have been widely and safely used by the general public for their photoprotective properties, including prevention of photocarcinogenesis and photoaging and management of photodermatoses for more than 40 years. FDA’s Sunscreen Monograph rule has identified the permitted active ingredients (UV-filters) for sunscreens since 1978. -
FDA Proposes Sunscreen Regulation Changes February 2019
FDA Proposes Sunscreen Regulation Changes February 2019 The U.S. Food and Drug Administration (FDA) regulates sunscreens to ensure they meet safety and eectiveness standards. To improve the quality, safety, and eectiveness of sunscreens, FDA issued a proposed rule that describes updated proposed requirements for sunscreens. Given the recognized public health benets of sunscreen use, Americans should continue to use broad spectrum sunscreen with SPF 15 or higher with other sun protective measures as this important rulemaking eort moves forward. Highlights of FDA’s Proposals Sunscreen active ingredient safety and eectiveness Two ingredients (zinc oxide and titanium dioxide) are proposed to be safe and eective for sunscreen use and two (aminobenzoic acid (PABA) and trolamine salicylate) are 1 proposed as not safe and eective for sunscreen use. FDA proposes that it needs more safety information for the remaining 12 sunscreen ingredients (cinoxate, dioxybenzone, ensulizole, homosalate, meradimate, octinoxate, octisalate, octocrylene, padimate O, sulisobenzone, oxybenzone, avobenzone). New proposed sun protection factor Sunscreen dosage forms (SPF) and broad spectrum Sunscreen sprays, oils, lotions, creams, gels, butters, pastes, ointments, and sticks are requirements 2 proposed as safe and eective. FDA 3 • Raise the maximum proposed labeled SPF proposes that it needs more data for from SPF 50+ to SPF 60+ sunscreen powders. • Require any sunscreen SPF 15 or higher to be broad spectrum • Require for all broad spectrum products SPF 15 and above, as SPF increases, broad spectrum protection increases New proposed label requirements • Include alphabetical listing of active ingredients on the front panel • Require sunscreens with SPF below 15 to include “See Skin Cancer/Skin Aging alert” on the front panel 4 • Require font and placement changes to ensure SPF, broad spectrum, and water resistance statements stand out Sunscreen-insect repellent combination 5 products proposed not safe and eective www.fda.gov. -
Kroger Co Disclaimer: Most OTC Drugs Are Not Reviewed and Approved by FDA, However They May Be Marketed If They Comply with Applicable Regulations and Policies
SUNSCREEN- avobenzone, homosalate, octisalate, octocrylene, oxybenzone lotion The Kroger Co Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. ---------- Kroger 711 Active Ingredients Avobenzone 3% Homosalate 13% Octisalate 5% Octocrylene 7% Oxybenzone 4% Purpose Sunscreen Use helps prevent sunburn if used as directed with other sun protections measures (see Directions), decreases the rist of skin cancer and early skin aging caused by the sun Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove Stop use and ask a doctor if rash occurs Keep out of reach of children if swallowed, get medical help or contact a Poison Control Center right away Directions apply liberally 15 minutes before sun exposure reapply: after 80 minutes of swimming or sweating immediately after towel drying at least every 2 hours Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk use a reqularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeved shirts, pants, hats and sunglasses children under 6 months of age: Ask a doctor Other Information Protect the product from excessive heat and direct sun Inactive ingredients water, sorbitol, triethanolamine, VP/eicosene copolymer, stearic acid, sorbitan isostearate, aluminum starch octenylsuccinate, benzyl alcohol, dimethicone, tocopheryl, chlorphenesin, polyglyceryl-3 distearate, fragrance, carbomer, disodium EDTA Questions or comments? 1-800-632-6900 Adverse Reaction DISTRIBUTED BY THE KROGER CO.